ArticleFuture oncology (London, England)2020
What the oncologist needs to know about COVID-19 infection in cancer patients.
Article in Future oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.Oncoimmunology · 2020Pooled it
- Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.British journal of cancer · 2021Observational
- Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021Review
- The impact of COVID-19 pandemic on colorectal cancer patients: a single-center retrospective study.BMC gastroenterology · 2021Article
- Should we screen patients with hematologic malignancies for COVID-19?Hematological oncology · 2020Review
- Article
- COVID-19: Thoracic Diagnostic Interventional Procedures in Troubled Times.Archivos de bronconeumologia · 2020Article
- Is blood transfusion safe during the COVID-19 pandemic?Future science OA · 2020Article
- Bladder cancer during the COVID-19 pandemic: the calm before the storm?Future science OA · 2020Article
- The management of patients with metastatic prostate cancer during the COVID-19 pandemic.Future oncology (London, England) · 2020Article
- On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.Journal for immunotherapy of cancer · 2020Review
- The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience.Future oncology (London, England) · 2020Article
- COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.